NIAID Banner Logo Image


1. 59396 OI-LS-361; SCIFINDER-OI-11/7/2006

Synthesis and in vitro anti-tubercular activity of a series of N'-(disubstitutedbenzoyl)isoniazid derivatives

Neves, Ivan Jr, Lourenco, Maria CS, de Miranda, Guilherme de BP, Vasconcelos, Thatyana RA, Pais, Karla C, de A, Jose dos P Jr, Wardell, Solange MSV, Wardell, James L, and de Souza, Marcus VN

Letters in Drug Design & Discovery 2006. 3(6): 424-428

2. 59397 OI-LS-361; PUBMED-OI-11/13/2006

Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis

Seidel, M, Alderwick, LJ, Sahm, H, Besra, GS, and Eggeling, L

Glycobiology 2006.


3. 59398 OI-LS-361; SCIFINDER-OI-11/7/2006

Activity of 6-O-substituted macrolides against Mycobacterium tuberculosis

Zhu, Zhaohai, Petukhova, Valentina Z, Pan, Dahua, Wan, Baojie, Wang, Yuehong, Krasnykh, Olga, Yu, Gengli, Schellinger, Kate, and Franzblau, Scott G

Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10-14, 2006 2006.: MEDI-349

4. 59399 OI-LS-361; PUBMED-OI-11/13/2006

Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth

Long, MC, Allan, PW, Luo, MZ, Liu, MC, Sartorelli, AC, and Parker, WB

J Antimicrob Chemother 2006.


5. 59400 OI-LS-361; SCIFINDER-OI-11/7/2006

Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity

Mueller, Daniela, Krick, Anja, Kehraus, Stefan, Mehner, Christian, Hart, Mark, Kuepper, Frithjof C, Saxena, Krishna, Prinz, Heino, Schwalbe, Harald, Janning, Petra, Waldmann, Herbert, and Koenig, Gabriele M

Journal of Medicinal Chemistry 2006. 49(16): 4871-4878

6. 59401 OI-LS-361; PUBMED-OI-11/13/2006

Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion

Harris, JE, Green, JA, Elkington, PT, and Friedland, JS

J Leukoc Biol 2006.


7. 59402 OI-LS-361; PUBMED-OI-11/13/2006


Kanda, T, Steele, R, Ray, R, and Ray, RB

J Virol 2006.


8. 59403 OI-LS-361; SCIFINDER-OI-11/7/2006

Novel antituberculosis compounds, hirsutellones A, C, and C

Isaka, Masahiko, Hywel-Jones, Nigel L, Somrithipol, Sayanh, Kirtikara, Kanyawim, Palittapongarnpim, Prasit, and Thebtaranonth, Yodhathai

PATENT: US 2006122252 ISSUE DATE: 20060608

APPLICATION: 2005-23378 PP: 21 pp.

ASSIGNEE: (National Center for Genetic Engineering, Thailand and Biotechnology, National Science & Technology Development Agency

9. 59404 OI-LS-361; PUBMED-OI-11/13/2006

Multidrug-resistant tuberculosis management in resource-limited settings

Nathanson, E, Lambregts-van, Weezenbeek C, Rich, ML, Gupta, R, Bayona, J, Blondal, K, Caminero, JA, Cegielski, JP, Danilovits, M, Espinal, MA, Hollo, V, Jaramillo, E, Leimane, V, Mitnick, CD, Mukherjee, JS, Nunn, P, Pasechnikov, A, Tupasi, T, Wells, C, and Raviglione, MC

Emerg Infect Dis 2006. 12(9): 1389-97


10. 59405 OI-LS-361; PUBMED-OI-11/13/2006

Synthesis and biological evaluation of 4-methylideneisoxazolidin-5-ones - A new class of highly cytotoxic alpha-methylidene-gamma-lactones

Rozalski, M, Krajewska, U, Panczyk, M, Mirowski, M, Rozalska, B, Wasek, T, and Janecki, T

Eur J Med Chem 2006.


11. 59406 OI-LS-361; SCIFINDER-OI-11/7/2006

The 5-Deoxy-5-methylthio-xylofuranose Residue in Mycobacterial Lipoarabinomannan. Absolute Stereochemistry, Linkage Position, Conformation, and Immunomodulatory Activity

Joe, Maju, Sun, Daniel, Taha, Hashem, Completo, Gladys C, Croudace, Joanne E, Lammas, David A, Besra, Gurdyal S, and Lowary, Todd L

Journal of the American Chemical Society 2006. 128(15): 5059-5072

12. 59407 OI-LS-361; PUBMED-OI-11/13/2006

In Vitro Inhibition of Toxoplasma gondii by Four New Derivatives of Artemisinin

Jones-Brando, L, D'Angelo, J, Posner, GH, and Yolken, R

Antimicrob Agents Chemother 2006.


13. 59408 OI-LS-361; SCIFINDER-OI-11/7/2006

Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives

Guezel, Oezlen and Salman, Aydin

Bioorganic & Medicinal Chemistry 2006. 14(23): 7804-7815

14. 59409 OI-LS-361; SCIFINDER-OI-11/7/2006

<04 Article Title>

Kenyon, James and Trischman, Jacqueline

<10 Journal Title> 2006.(<24 Issue ID>): <25 Page(s)>

15. 59410 OI-LS-361; SCIFINDER-OI-11/7/2006

Synthesis and antituberculosis activity of 2-(aryl/alkylamino)-5-(4-aminophenyl)-1,3,4-thiadiazoles and their Schiff bases

Solak, Nilufer and Rollas, Sevim

ARKIVOC (Gainesville, FL, United States) 2006.(12): 173-181

16. 59411 OI-LS-361; PUBMED-OI-11/13/2006

Editorial: The treatment of multi-drug resistant tuberculosis - a return to the pre-antibiotic era?

Olle-Goig, JE

Trop Med Int Health 2006. 11(11): 1625-8


17. 59412 OI-LS-361; SCIFINDER-OI-11/7/2006

Structure-activity relationships at the 5-position of thiolactomycin: An intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli

Kim, Pilho, Zhang, Yong-Mei, Shenoy, Gautham, Nguyen, Quynh-Anh, Boshoff, Helena I, Manjunatha, Ujjini H, Goodwin, Michael B, Lonsdale, John, Price, Allen C, Miller, Darcie J, Duncan, Ken, White, Stephen W, Rock, Charles O, Barry, Clifton E III, and Dowd, Cynthia S

Journal of Medicinal Chemistry 2006. 49(1): 159-171

18. 59413 OI-LS-361; PUBMED-OI-11/13/2006

Cost of treatment for multidrug-resistant tuberculosis in South Korea

Kang, YA, Choi, YJ, Cho, YJ, Lee, SM, Yoo, CG, Kim, YW, Han, SK, Shim, YS, and Yim, JJ

Respirology 2006. 11(6): 793-8


19. 59414 OI-LS-361; PUBMED-OI-11/13/2006

siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations

Konishi, M, Wu, CH, Kaito, M, Hayashi, K, Watanabe, S, Adachi, Y, and Wu, GY

J Viral Hepat 2006. 13(11): 756-61


20. 59415 OI-LS-361; SCIFINDER-OI-11/7/2006

Design and synthesis of a novel nanomolar inhibitor of Toxoplasma gondii dihydrofolate reductase, its salt form and analogs

Gangjee, Aleem, Lin, Xin, Biondo, Lisa R, and Queener, Sherry F

Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10-14, 2006 2006.: MEDI-363

21. 59416 OI-LS-361; PUBMED-OI-11/13/2006

Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis

Gao, XF, Wang, L, Liu, GJ, Wen, J, Sun, X, Xie, Y, and Li, YP

Int J Tuberc Lung Dis 2006. 10(10): 1080-90


22. 59417 OI-LS-361; PUBMED-OI-11/13/2006

Antituberculosis drug resistance in the south of Vietnam: prevalence and trends

Huong, NT, Lan, NT, Cobelens, FG, Duong, BD, Co, NV, Bosman, MC, Kim, SJ, van, Soolingen D, and Borgdorff, MW

J Infect Dis 2006. 194(9): 1226-32


23. 59418 OI-LS-361; WOS-OI-11/6/2006

What is Cryptosporidium? Reappraising its biology and phylogenetic affinities

Barta, JR and Thompson, RCA

TRENDS IN PARASITOLOGY 2006. 22(10): 463-468, 6


24. 59419 OI-LS-361; SCIFINDER-OI-11/7/2006

In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs

Tay, ST, Haryanty, TTanty, Ng, KP, Rohani, MY, and Hamimah, H

Mycoses 2006. 49(4): 324-330

25. 59420 OI-LS-361; WOS-OI-11/6/2006

Antiprotozoal and antimicrobial activities of Centaurea species growing in Turkey

Karamenderes, C, Khan, S, Tekwani, BL, Jacob, MR, and Khan, IA

PHARMACEUTICAL BIOLOGY 2006. 44(7): 534-539, 6


26. 59421 OI-LS-361; SCIFINDER-OI-11/7/2006

Preparation of 2-thienylacetylenes as antiviral agents

Wunberg, Tobias, Baumeister, Judith, Gottschling, Dirk, Henninger, Kerstin, Koletzki, Diana, Pernerstorfer, Josef, Urban, Andreas, Birkmann, Alexander, Harrenga, Axel, and Lobell, Mario

PATENT: WO 2006072348 ISSUE DATE: 20060713

APPLICATION: 2005 PP: 83 pp.

ASSIGNEE: (Aicuris Gmbh & Co. KG, Germany

27. 59422 OI-LS-361; WOS-OI-11/6/2006

Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus

Cheng, YJ, Niu, JJ, Zhang, YY, Huang, JW, and Li, QG

JOURNAL OF CLINICAL MICROBIOLOGY 2006. 44(10): 3557-3561, 5


28. 59423 OI-LS-361; WOS-OI-11/6/2006

Evaluation of molecular-beacon, TaqMan, and fluorescence resonance energy transfer probes for detection of antibiotic resistance-conferring single nucleotide Polymorphisms in mixed Mycobacterium tuberculosis DNA extracts

Yesilkaya, H, Meacci, F, Niemann, S, Hillemann, D, Rusch-Gerdes, S, Barer, MR, Andrew, PW, and Oggioni, MR

JOURNAL OF CLINICAL MICROBIOLOGY 2006. 44(10): 3826-3829, 4


29. 59424 OI-LS-361; WOS-OI-11/6/2006

A new antifungal macrolide, eushearilide, isolated from Eupenicillium shearii

Hosoe, T, Fukushima, K, Takizawa, K, Itabashi, T, Kawahara, N, Vidotto, V, and Kawai, KI

JOURNAL OF ANTIBIOTICS 2006. 59(9): 597-600, 4


30. 59425 OI-LS-361; WOS-OI-11/6/2006

Biochemical and functional characterization of triosephosphate isomerase from Mycobacterium tuberculosis H37Rv

Mathur, D, Malik, G, and Garg, LC

FEMS MICROBIOLOGY LETTERS 2006. 263(2): 229-235, 7


31. 59426 OI-LS-361; WOS-OI-11/6/2006

Design, synthesis, and antifungal activities in vitro of novel tetrahydroisoquinoline compounds based on the structure of lanosterol 14 alpha-demethylase (CYP51) of fungi

Zhu, J, Lu, JG, Zhou, YJ, Li, YW, Cheng, J, and Zheng, CH



32. 59427 OI-LS-361; WOS-OI-11/13/2006

Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats

Guitard, J, Menotti, J, Desveaux, A, Alimardani, P, Porcher, R, Derouin, F, and Kapel, N

PARASITOLOGY RESEARCH 2006. 99(5): 522-527, 6


33. 59428 OI-LS-361; WOS-OI-11/13/2006

Are second-line drugs necessary to control mulfidrug-resistant tuberculosis?

Nardell, EA and Mitnick, CD

JOURNAL OF INFECTIOUS DISEASES 2006. 194(9): 1194-1196, 3


34. 59429 OI-LS-361; WOS-OI-11/13/2006

Mucoralactone A: An unusual steroid from the liquid culture of Mucor plumbeus

Ata, A, Conci, LJ, and Orhan, I

HETEROCYCLES 2006. 68(10): 2097-+, 11


35. 59430 OI-LS-361; WOS-OI-11/13/2006

Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities

Tomioka, H

CURRENT PHARMACEUTICAL DESIGN 2006. 12(31): 4047-4070, 24


36. 59431 OI-LS-361; WOS-OI-11/13/2006

Bioactive constituents of the root bark of Artocarpus rigidus subsp rigidus

Namdaung, U, Aroonrerk, N, Suksamrarn, S, Danwisetkanjana, K, Saenboonrueng, J, Arjchomphu, W, and Suksamrarn, A

CHEMICAL & PHARMACEUTICAL BULLETIN 2006. 54(10): 1433-1436, 4


37. 59432 OI-LS-361; WOS-OI-11/13/2006

Sulfate metabolism in mycobacteria

Schelle, MW and Bertozzi, CR

CHEMBIOCHEM 2006. 7(10): 1516-1524, 9


38. 59433 OI-LS-361; WOS-OI-11/13/2006

Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents

Zhao, GY, Miller, MJ, Franzblau, S, Wan, BJ, and Mollmann, U



39. 59434 OI-LS-361; WOS-OI-11/13/2006

Now, later or never? Challenges associated with hepatitis C treatment

McNally, S and Temple-Smith, M



If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023